Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine

Lupus Sci Med. 2021 Aug;8(1):e000519. doi: 10.1136/lupus-2021-000519.
No abstract available

Keywords: antirheumatic agents; lupus erythematosus; systemic; therapeutics.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents*
  • Azathioprine / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic* / drug therapy
  • Mercaptopurine / therapeutic use
  • Pregnancy

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Mercaptopurine
  • Azathioprine

Grants and funding